Is it fair to ask ?

Why has the price gone up ? We know the data from the Phase III was gosh darn strong !

Gee. It was at $.56 just at the beginning of the year. What is that? UP 110%? Please correct me if I'm wrong. I insist.

Now I am reading the quotes:

"""""The completed study evaluated 129 procedure compliant patients who had a total of 214 vital blue dye positive lymph nodes confirmed."""""

129 "procedure compliant patients" ?

We know that there were 130 patients but one turned out to have bilateral disease so they were excluded from the trial . That criteria was spelled out in the enrollment criteria plainly . Correct me if I am wrong.

I am very familiar with the term procedure compliant patients, although many who are less informed do not understand the success of the trial .

It also appears that the trial had an unexpected upside surprise for Lymphoseek as it found 85 Sentinel Nodes missed by the Gold Standard Blue Dye. Did anyone else see that result ? WOW !

----- Is it fair to ask ?

We know there were 130 enrolled patients but one was dismissed for having bilateral disease.

It's good to see that the company NEOP has filed the complete trial results with the FDA and is publishing those results in all the peer reviews as is USUAL and CUSTOMARY !